SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950134-05-022335
Filing Date
2005-11-30
Accepted
2005-11-30 06:03:18
Documents
5
Period of Report
2005-11-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d30856e8vk.htm 8-K 17633
2 LICENSE AGREEMENT d30856exv10w1.htm EX-10.1 144479
3 PRESS RELEASE d30856exv99w1.htm EX-99.1 15927
4 GRAPHIC d30856d3085600.gif GRAPHIC 7116
5 GRAPHIC d30856d3085601.gif GRAPHIC 3681
  Complete submission text file 0000950134-05-022335.txt   194773
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 051233201
SIC: 2836 Biological Products, (No Diagnostic Substances)